Tag Archives: agn

Salix, Skyworks Lead 6 IBD50 EarningsReports On Tap

Earnings season continues to barrel forward, and investors are anticipating results from several top drugmakers this upcoming week. This week’s IBD 50, a roundup of top-rated growth stocks with solid fundamentals, boasts six companies reporting earnings this week, including four pharma plays. Salix Pharmaceuticals (SLXP) has made headlines in recent months as both Allergan (AGN) and Actavis (ACT) have been rumored to be eyeing the gastrointestinal

Salix, Skyworks Lead 6 IBD 50 Earnings Reports On Tap

Earnings season continues to barrel forward, and investors are anticipating results from several top drugmakers this upcoming week. This week’s IBD 50, a roundup of top-rated growth stocks with solid fundamentals, boasts six companies reporting earnings this week, including four pharma plays. Salix Pharmaceuticals (SLXP) has made headlines in recent months as both Allergan (AGN) and Actavis (ACT) have been rumored to be eyeing the gastrointestinal

Video: Allergan Lifts Views; Valeant Suggests Higher Bid

Specialty drugmaker Allergan (AGN) reported solid Q3 results and raised its guidance Monday, as hostile suitor Valeant Pharmaceuticals International (VRX) said that it might raise its bid for the company again. Allergan’s Q3 earnings rose 45% over the year-earlier quarter to $1.78 a share, excluding one-time items. The result was at the high end of the guidance of $1.76 to $1.78 that Allergan gave on Oct. 9, though analysts’ consensus was still